Affiliation:
1. Department of Biology, China State Institute of Pharmaceutical Industry, Shanghai 201203, China
Abstract
Site-specific integration is an important approach used to address the problem of unstable cell lines in industry. In this study, we observed a reduction in the gene copy number and antibody production in a CHOK1 cell line BA03 capable of high antibody expression. We identified a new integration site named locus 7 in the intron region of the parva gene through sequencing, FISH, and genome walking. We demonstrate that the integration of the exogenous gene at this locus does not affect the transcription of the parva and, therefore, has a minimal impact on cell growth. We designed sgRNA and donor vectors to integrate the etanercept-coding gene into locus 7 and obtained a cell line, SSI-4. We performed a passaged stability study on SSI-4 and proved the possibility of the stable, site-specific integration of exogenous genes at this locus in terms of integration site, copy number, expression level, and cell growth. In summary, our study has identified a new integration site suitable for site-specific integration, which lays the foundation for the subsequent development of site-specific integration cell lines.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference26 articles.
1. Genetics of somatic mammalian cells, VII. Induction and isolation of nutritional mutants in Chinese hamster cells;Kao;Proc. Natl. Acad. Sci. USA,1968
2. Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome;Lewis;Nat. Biotechnol.,2013
3. First CHO genome;Wurm;Nat. Biotechnol.,2011
4. The chromosomes of CHO, an aneuploid Chinese hamster cell line: G-band, C-band, and autoradiographic analyses;Deaven;Chromosoma,1973
5. Efficient mAb production in CHO cells with optimized signal peptide, codon, and UTR;You;Appl. Microbiol. Biotechnol.,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献